The data showed that in the control group, the tumor tissue grew rapidly, whereas in the CDDP treatment, PLK2 inhibitor treatment, and the combination treatment groups, tumor growth was significantly inhibited (P < .05). This evidence concerns the gene PLK2 and neoplasm.